Securing a Proof of Concept for an Advance Care Planning Support App
First written in FY2022-Q2. 9 of 17 entries say "Restated". Latest entry: FY2026.
No other company in this theme has enough history to compare yet.
- FY2026AdvancedAnnual report
「The exploratory study aimed at obtaining proof of concept (PoC) has been completed, and the results have been presented in an oral session at the American Society of Clinical Oncology. A company-sponsored clinical trial, equivalent to a Phase II clinical trial, is currently being conducted.」
For the ACP support app, the company moved to the stage of conducting a company-sponsored clinical trial after completing the exploratory study. - FY2026-H1RestatedAnnual report
「For the app supporting advance care planning for patients with advanced cancer, enrollment has begun in a company-sponsored clinical trial (equivalent to a Phase II clinical trial). For this App, we have established an industry-academia collaborative course with The Jikei University School of Medicine and will seek to implement it in society.」
For the advance care planning support app, the company continues to pursue implementation in society through an industry-academia collaborative program with The Jikei University School of Medicine after beginning subject enrollment in the company-sponsored clinical trial. - FY2025AdvancedAnnual report
「For the app supporting advance care planning for patients with advanced cancer, subject enrollment has begun in a company-sponsored clinical trial equivalent to a Phase II clinical trial. The company has established an industry-academia collaborative program with The Jikei University School of Medicine for this app and plans to pursue implementation in society.」
After completing the exploratory study, the company began subject enrollment in a company-sponsored clinical trial. The company also stated its policy of pursuing implementation in society through an industry-academia collaborative program with The Jikei University School of Medicine. - FY2025-H1AdvancedAnnual report
「For the other pipelines, the app supporting advance care planning for patients with advanced cancer has completed an exploratory study equivalent to a Phase II clinical trial, and preparations are under way for the next study. The company has established an industry-academia collaborative program with The Jikei University School of Medicine for this app and plans to pursue implementation in society.」
In addition to preparing for the next study after completing the exploratory study, the company has established an industry-academia collaborative program with The Jikei University School of Medicine, clearly indicating that it is pursuing implementation in society. - FY2024AdvancedAnnual report
「The exploratory study to obtain proof of concept (PoC) has now been completed, and the results were presented in an oral session at the American Society of Clinical Oncology. The company continues to consider the protocol for future clinical trials, aiming to discontinue inappropriate treatment and improve patients' own anxiety and depressive symptoms through the provision of software as a medical device for advance care planning.」
In addition to completing the exploratory study and presenting at an academic conference, the company has progressed to the stage of pursuing implementation in society through an industry-academia collaborative program with The Jikei University School of Medicine. - FY2024-Q3AdvancedAnnual report
「For the other pipelines, development is also progressing smoothly, with the renal rehabilitation app for patients with chronic kidney disease and the app supporting advance care planning for patients with advanced cancer having completed exploratory studies equivalent to Phase II clinical trials.」
The advance care planning support app has progressed from the stage of completing subject enrollment in its exploratory study to the stage of completing the study. - FY2024-Q2RestatedAnnual report
「Development is progressing smoothly, with subject enrollment completed in exploratory studies equivalent to Phase II clinical trials for both the app supporting advance care planning for patients with advanced cancer and the renal rehabilitation app for patients with chronic kidney disease.」
The advance care planning support app continues as a pipeline pursuing proof of concept (PoC), with subject enrollment completed in its exploratory study. - FY2024-Q1RestatedAnnual report
「For the app supporting advance care planning for patients with advanced cancer and the renal rehabilitation app for patients with chronic kidney disease, subject enrollment has been completed in exploratory studies equivalent to Phase II clinical trials, respectively.」
The advance care planning support app continues to be described as a pipeline pursuing proof of concept (PoC) through an exploratory study. - FY2023RestatedAnnual report
「The company is currently conducting an exploratory study to obtain proof of concept (PoC), with the aim of discontinuing inappropriate treatment and improving patients' own anxiety and depressive symptoms through the provision of software as a medical device for advance care planning.」
The company continues to pursue proof of concept (PoC) for the advance care planning support app through an exploratory study. - FY2023-Q3AdvancedAnnual report
「For the other pipelines, subject enrollment has also been completed in an exploratory study to obtain proof of concept (PoC) for an app supporting advance care planning and in an exploratory study of a renal rehabilitation app for patients with chronic kidney disease.」
The advance care planning support app has progressed from the preparation and initiation stage of its exploratory study to the stage of completing subject enrollment. - FY2023-Q2RestatedAnnual report
「The company also began an exploratory study equivalent to a Phase II clinical trial to obtain proof of concept (PoC) for an app supporting advance care planning.」
The application supporting advance care planning remains at the stage of having begun the exploratory study and aiming to obtain proof of concept. - FY2023-Q1RestatedAnnual report
「For pipeline programs other than the therapeutic application for insomnia disorder, the Company has begun an exploratory study, equivalent to a Phase II clinical trial, to obtain proof of concept for an application supporting advance care planning.」
The application supporting advance care planning remains at the stage of having begun the exploratory study and aiming to obtain proof of concept. - FY2022RestatedAnnual report
「The Company has begun an exploratory study, equivalent to a Phase II clinical trial, to obtain proof of concept for an application supporting advance care planning.」
The stage of having begun the exploratory study and aiming to obtain proof of concept continues. - FY2022-Q3AdvancedAnnual report
「The Company has also begun an exploratory study to obtain proof of concept for an application supporting advance care planning.」
The disclosure explicitly states that the exploratory study has begun, compared with the previous description that the exploratory study was being conducted. - FY2022-Q2First statedAnnual report
「For pipeline programs other than the Application, the Company is conducting an exploratory study to obtain proof of concept for an application supporting advance care planning.」
The objective is to obtain proof of concept, with an exploratory study being conducted for that purpose.